等待开盘 05-20 09:30:00 美东时间
+0.120
+0.88%
今日重点评级关注:Needham:维持Artiva Biotherapeutics"买入"评级,目标价从18美元升至41美元;HC Wainwright & Co.:维持SAB Biotherapeutics"买入"评级,目标价从7美元升至10美元
05-13 11:46
今日重点评级关注:Citizens:维持Avalo Therapeutics"跑赢大市"评级,目标价从52美元升至62美元;BTIG:维持Avalo Therapeutics"买入"评级,目标价从40美元升至58美元
05-07 12:37
Barclays analyst Luke Sergott maintains Fortrea Holdings (NASDAQ:FTRE) with a Equal-Weight and raises the price target from $11 to $16.
05-06 22:57
Fortrea Holdings shares are trading higher after the company reported better-th...
05-05 21:19
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
Fortrea Holdings (NASDAQ:FTRE) affirms FY2026 sales outlook from $2.550 billion-$2.650 billion to $2.550 billion-$2.650 billion vs $2.594 billion estimate.
05-05 18:01
Fortrea to report first-quarter results, host conference call Fortrea will release first-quarter 2026 financial results before market open on May 5, 2026. Management will host earnings conference call at 8:00 a.m. ET on May 5, 2026. Live webcast will be available via investors.fortrea.com . Disclaim
04-21 20:45
今日重点评级关注:Ascendiant Capital:维持IGC Pharma"买入"评级,目标价从5美元升至5.25美元;Benchmark:维持Direct Digital Holdings"投机性买入"评级,目标价从2美元升至8美元
04-09 10:15
Evercore ISI Group analyst Elizabeth Anderson maintains Fortrea Holdings (NASDAQ:FTRE) with a Outperform and lowers the price target from $25 to $14.
04-08 23:26
今日重点评级关注:Evercore ISI集团:维持Caribou Biosciences"跑赢大市"评级,目标价从11美元升至13美元;富国银行:上调uniQure评级至"超配",目标价从15美元升至60美元
03-10 15:05